Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calvit is an injectable pharmaceutical product manufactured by Merlin Pharmaceuticals (Merlin Pharma (P) Limited), an Indian generic drug manufacturer. It is a combination formulation typically consisting of calcium levulinate, vitamin D3 (cholecalciferol), and vitamin B12 (cyanocobalamin). The product is indicated for the treatment of calcium deficiencies, hypocalcemia, and metabolic bone disorders such as rickets and osteomalacia. By providing a direct source of calcium along with vitamin D3 to enhance absorption and vitamin B12 to support metabolic processes, Calvit serves as a therapeutic supplement in both human and veterinary medicine. It is marketed as a proprietary injectable solution, reflecting its status as a branded generic within the Indian pharmaceutical market.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Calvit.